comparemela.com

Latest Breaking News On - Obatala sciences - Page 3 : comparemela.com

Obatala Sciences raises more funds to drive diverse research

The New Orleans-based biotech startup recently closed a $3 million Series A funding round.

Xiying wuJeffery kimbleOchsner lafayetteElevate capital fundObatala sciencesCharity hospitalFreeman school of businessMaterials research instituteOrleans bioinnovation centerHealthcare innovation fundPennington biomedical research centerUniversity of new orleansTechnology parkTulane school of medicineNew orleansTrivia frazier

Obatala Sciences Closes $3 Million Series A Funding Round Co-led by être Venture Capital and Ochsner Health

Obatala Sciences Closes $3 Million Series A Funding Round Co-led by être Venture Capital and Ochsner Health - read this article along with other careers information, tips and advice on BioSpace

United statesNew orleansUniversity of new orleansOchsner lafayetteJennifer kuanElevate capital fundObatala sciencesOchsner healthResearch park districtObatala sciences incHealthcare innovation fundVenture capitalBenson capital partnersBusiness wireNorth americanObatala science

Biotech Startup Obatala Sciences Raises $3M for Organ-on-a-Chip for Research

Obatala Sciences, a biotech startup speeding up therapies for obesity, diabetes, and cancer across diverse populations raises $3M..

United statesOchsner lafayetteJennifer kuanElevate capital fundObatala sciencesBiotech startup obatala sciencesResearch park districtObatala sciences incResearch trivia frazierHealthcare innovation fundFunding accelerates commercialisation of researchUniversity of new orleansBiotech startup obatala sciences raisesTrivia frazierShould knowNew orleans

Obatala Sciences Closes $3M Series A Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Ochsner lafayetteElevate capital fundObatala sciencesHealthcare innovation fundNew orleansVenture capitalBenson capital partners

Obatala Sciences Closes $3 Million Series A Funding Round Co-led by être Venture Capital and Ochsner

-Funding accelerates commercialization of research-enabling solutions to speed up therapies for obesity, diabetes, and cancer across diverse populations Obatala Sciences’ solutions provide research scientists in pharmaceutical companies, biotech, academia, and government laboratories with models that more accurat.

United statesNew orleansUniversity of new orleansOchsner lafayetteJennifer kuanElevate capital fundObatala sciencesOchsner healthResearch park districtHealthcare innovation fundObatala scienceVenture capitalBenson capital partnersNorth americanGulf southConnected health

vimarsana © 2020. All Rights Reserved.